Deutsch English Français

Contact

EP2227452

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...

Extract from the Register of European Patents

EP About this file: EP2227452

EP2227452 - PYRIDINE COMPOUNDS [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 13.03.2015 Database last updated on 07.06.2024
Most recent event Tooltip	13.03.2015	Application deemed to be withdrawn	published on 15.04.2015 [2015/16]
Applicant(s)	For all designated states F. Hoffmann-La Roche AG Grenzacherstrasse 124 4070 Basel / CH
	[N/P]
Former [2010/37]	For all designated states F. Hoffmann-La Roche AG Grenzacherstrasse 124 4070 Basel / CH
Inventor(s)	01 / HAAP, Wolfgang Fridolin-Engel-Strasse 51 79540 Loerrach / DE
	02 / HEBEISEN, Paul St. Alban-Ring 184 CH-4052 Basel / CH
	03 / KITAS, Eric A. Eichbergweg 4 CH-4147 Aesch BL / CH
	04 / KUHN, Bernd Hinterlindenweg 26a CH-4153 Reinach BL / CH
	05 / MOHR, Peter Benkenstrasse 26 CH-4054 Basel / CH
	06 / WESSEL, Hans Peter Leonhard-Mueller-Strasse 2 79418 Schliengen / DE
	[2010/37]
Representative(s)	Waschbüsch, Klaus F. Hoffmann-La Roche AG Corporate Law Patents Building 675 / 3rd Floor 4070 Basel / CH
	[N/P]
Former [2010/37]	Waschbüsch, Klaus F. Hoffmann-La Roche AG Corporate Law Patents Building 675 / 3rd Floor 4070 Basel / CH
Application number, filing date	08853903.6	20.11.2008
	[2010/37]
	WO2008EP65911
Priority number, date	EP20070122017	30.11.2007 Original published format: EP 07122017
	[2010/37]
Filing language	EN
Procedural language	EN
Publication	Type:	A2 Application without search report
	No.:	WO2009068468
	Date:	04.06.2009
	Language:	EN
	[2009/23]
	Type:	A2 Application without search report
	No.:	EP2227452
	Date:	15.09.2010
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 04.06.2009 takes the place of the publication of the European patent application.
	[2010/37]
Search report(s)	International search report - published on:	EP	22.04.2010
Classification	IPC:	C07D213/75, C07D401/12, C07D405/12, C07D409/12, C07D409/14, C07D413/14, A61K31/64, A61P3/00	[2010/37]
	CPC:	C07D213/75 (EP,US); A61P3/00 (EP); A61P3/10 (EP); A61P9/10 (EP); C07D401/12 (EP,US); C07D405/12 (EP,US); (+) C07D409/12 (EP,US); C07D409/14 (EP,US); C07D413/14 (EP,US) (-)
Designated contracting states	AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR [2010/37]
Title	German:	PYRIDINVERBINDUNGEN	[2010/37]
	English:	PYRIDINE COMPOUNDS	[2010/37]
	French:	COMPOSÉS DE PYRIDINE	[2010/37]
Entry into regional phase	30.06.2010	National basic fee paid
	22.10.2010	Designation fee(s) paid
	22.10.2010	Examination fee paid
Examination procedure	01.04.2010	Request for preliminary examination filed International Preliminary Examining Authority: EP
	05.08.2010	Amendment by applicant (claims and/or description)
	22.10.2010	Examination requested [2010/48]
	03.07.2014	Despatch of a communication from the examining division (Time limit: M04)
	14.11.2014	Application deemed to be withdrawn, date of legal effect [2015/16]
	08.12.2014	Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2015/16]
Divisional application(s)	The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 03.07.2014
Fees paid	Renewal fee
	22.10.2010	Renewal fee patent year 03
	07.11.2011	Renewal fee patent year 04
	07.11.2012	Renewal fee patent year 05
	02.12.2013	Renewal fee patent year 06
	01.12.2014	Renewal fee patent year 07
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited in	International search	[XY]DD9688 (VEB CHEMISCHE FABRIK VON HEYDEN) [X] 1,2,13-18,28,31 * example 10; claim 1 * * page 2, line 11 - line 31 * [Y] 22;
		[X]DE1011413 (BOEHRINGER & SOEHNE GMBH) [X] 1,2,6,7,13-21,23-31 * column 1, line 1 - line 50 * * column 7, line 49 - line 63 *;
		[X]GB797474 (BOEHRINGER & SOEHNE GMBH) [X] 1,2,13-17,19-21,23-31 * example 7; claim 1 * * page 1, line 8 - line 56 *;
		[X]US4293330 (LEVITT GEORGE) [X] 1,2,13-18,28,31 * abstract *;
		[X]EP0503162 (HOECHST AG [DE]) [X] 1,2,13-17,23,25,28,31 * example 28; claims 1,9 *;
		[X]WO9630341 (POLYCHIP PHARMACEUTICALS PTY [AU], et al) [X] 1,2,6,7,13-21,23-31 * examples 2,8,9; claims 1,6,12,13; table 1 *;
		[X]US2002193596 (SEBTI SAID M [US], et al) [X] 1,2,13-18,23,25,28,31 * abstract *;
		[Y]DK200600313 (NOVO NORDISK AS [DK]) [Y] 1-5,10-21,23-31 * claims 1,2,8,10 * * page 40, line 16 - page 45, line 15 *;
		[XY] - ABOU OUF A A ET AL, "THIOPHENE SULPHONYLUREAS STRUCTURALLY RELATED TO ANTIDIABETIC DRUGS", JOURNAL OF DRUG RESEARCH EGYPT, DRUG RESEARCH AND CONTROL CENTER, GIZA, EG, (19740101), vol. 6, no. 2, ISSN 0368-1866, pages 123 - 129, XP009011580 [X] 1,2,8,9,13-21,23-31 * the whole document * [Y] 1-5,10-31
		[X] - RUSCHING H ET AL, "New Orally effective blood sugar reducing compounds//Neue peroral wirksame blutzckersenkende Substanzen", ARZNEIMITTEL FORSCHUNG. DRUG RESEARCH, ECV EDITIO CANTOR VERLAG, AULENDORF, DE, (1958), vol. 8, no. 7a, ISSN 0004-4172, pages 448 - 454, XP009088824 [X] 1,2,6-9,13-21,23-31 * the whole document *
		[XY] - WU T-A ET AL, "Synthesis of sulfonylureas", ZHONGHUA YAOXUE ZAZHI - CHINESE PHARMACEUTICAL JOURNAL, ZHONGGUO YAOXUEHUI, TAIPEI, TW, (19760101), vol. 28, no. 1-2, ISSN 1016-1015, pages 56 - 61, XP008111887 [X] 1,2,6,7,13-21,23-31 * page 56 - page 58; table 2; compounds XIA-XIE * [Y] 22
		[X] - HOLLAND, GERALD F., J. ORG. CHEM., (1961), vol. 26, pages 1662 - 1665, XP002563968 [X] 1,2,6-9,13-21,23-31 * the whole document * DOI: http://dx.doi.org/10.1021/jo01064a626
		[ ] - HCAPLUS, ACS, Database accession no. 55:143353(DN), URL: STN, XP002565943 [ ] * RN109067-68-7, 115035-59-1; column A *
		[X] - HOWBERT J J ET AL, "NOVEL AGENTS EFFECTIVE AGAINST SOLID TUMORS: THE DIARYLSULFONYLUREAS. SYNTHESIS, ACTIVITIES, AND ANALYSIS OF QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIPS", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, WASHINGTON, US, (1990), vol. 33, ISSN 0022-2623, pages 2393 - 2407, XP000919053 [X] 1,2,6,7,13-18,23,25,28,31 * abstract * DOI: http://dx.doi.org/10.1021/jm00171a013
		[ ] - HCAPLUS, ACS, Database accession no. 138:39539(DN), URL: STN, XP002565944 [ ] * RN1106302-95-7, -96-8; column A *
		[A] - LAI C ET AL, "Benzoxazole benzenesulfonamides as allosteric inhibitors of fructose-1,6-bisphosphatase", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, PERGAMON, ELSEVIER SCIENCE, GB, vol. 16, no. 7, ISSN 0960-894X, (20060401), pages 1807 - 1810, (20060401), XP025106972 [A] 1-5,12-31 * the whole document * DOI: http://dx.doi.org/10.1016/j.bmcl.2006.01.014

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.1.24; 34p